CorMedix News - CRMD

Company Name	Stock Ticker Symbol	Market	Type
CorMedix Inc	CRMD	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.21	-3.87%	5.21	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
5.50	5.13	6.22	5.28	5.42

more quote information »

Recent News

Date	Time	Source	Heading
4/19/2024	08:30	GLOBE	CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
4/15/2024	08:30	GLOBE	CorMedix Inc. Announces U.S. Inpatient Commercial..
3/12/2024	07:30	GLOBE	CorMedix Inc. Reports Fourth Quarter and Full Year 2023..
1/30/2024	17:26	EDGAR2	Form 8-K - Current report
1/18/2024	16:53	EDGAR2	Form 4/A - Statement of changes in beneficial ownership of..
1/17/2024	20:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/17/2024	20:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/17/2024	20:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/17/2024	20:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	08:39	EDGAR2	Form 8-K - Current report
12/14/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/21/2023	16:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/16/2023	16:11	EDGAR2	Form 8-K - Current report
11/14/2023	16:05	GLOBE	CorMedix Inc. Reports Third Quarter and Nine Month 2023..
10/30/2023	16:35	EDGAR2	Form 8-K - Current report
10/11/2023	08:30	GLOBE	CorMedix Inc. Announces Abstract Presentation at Upcoming..
9/13/2023	17:25	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
9/13/2023	17:20	EDGAR2	Form DEF 14A - Other definitive proxy statements
9/08/2023	16:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/08/2023	08:30	GLOBE	CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100..
8/30/2023	08:00	GLOBE	CorMedix Inc. Announces Issuance of U.S. Patent Covering..
8/17/2023	08:30	EDGAR2	Form 8-K - Current report
8/08/2023	08:12	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	07:45	EDGAR2	Form 8-K - Current report
8/08/2023	07:30	GLOBE	CorMedix Inc. Reports Second Quarter and Six Month 2023..
6/30/2023	16:40	EDGAR2	Form 8-K - Current report
6/30/2023	16:38	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
6/28/2023	22:57	GLOBE	CorMedix Inc. Announces Pricing of $40 Million Public..
6/28/2023	17:13	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
6/28/2023	16:07	GLOBE	CorMedix Inc. Announces Proposed Public Offering of Common..
6/21/2023	08:30	GLOBE	CorMedix Inc. Announces FDA Acceptance of Resubmission of..
6/15/2023	08:30	GLOBE	Cormedix Inc. Announces Strategic Initiative With Boston..
5/16/2023	07:00	GLOBE	CorMedix Inc. Announces Resubmission of New Drug Application..
5/15/2023	16:05	GLOBE	CorMedix Inc. Reports First Quarter 2023 Financial Results..
5/01/2023	08:30	GLOBE	CorMedix Inc. Announces Notice of Allowance for U.S. Patent..
4/26/2023	10:47	DJN	CorMedix Shares Drop 14% After Type A Meeting With FDA for..
4/26/2023	09:20	DJN	CorMedix to Resubmit NDA for DefenCath in May
4/26/2023	08:30	GLOBE	CorMedix Inc. Announces Regulatory, Manufacturing and..